PPT-Purpose Case #1 References
Author : joyce | Published Date : 2023-07-07
Case 3 Case Visuals Angiographic Pitfalls for Arterial Interventions Abdul Khan MD Gregory Woodhead MD PhD Hugh McGregor MD Mikin Patel MD MBA Charles Hennemeyer
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Purpose Case #1 References" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Purpose Case #1 References: Transcript
Case 3 Case Visuals Angiographic Pitfalls for Arterial Interventions Abdul Khan MD Gregory Woodhead MD PhD Hugh McGregor MD Mikin Patel MD MBA Charles Hennemeyer MD University of Arizona Department of Medical Imaging Department of Interventional Radiology. Purpose The purpose of this guideline is to assist nuclear medicine practitioners in recommending perform ing interpreting and reporting the results of bone scintigraphy II Background Information and Definitions WRECKER AND TOWING References: Procedure 12.200, Purpose: To specify the type of wrecker used and towing destination for each situation requiring the use of a wrecker. Policy: Department personnel wi Disease Progression. Program Goals. Introduction. Good News, Bad News. Case 1. Case 1: Initial CT Scan: Sigmoid Colorectal Tumor. Case 1: Multiple Lung Metastases. Case 1: Description (cont). Case 1: Light Progression in the Liver . Division of Grants Compliance and Oversight. Office of Policy for Extramural Research Administration, OER. National Institutes of Health, DHHS . NIH Regional Seminar – . Baltimore, MD. – June 2014. Goals. Case Study: Newly Diagnosed Low Volume Metastatic Disease. CHAARTED: Benefit of Docetaxel. Toxicity Grade 3 AE or Greater. Treating the Primary Tumor. Case Study, Continued. Abiraterone . COU-AA-302 Trial. Division of Grants Compliance and Oversight. Office of Policy for Extramural Research Administration, OER. National Institutes of Health, DHHS . NIH Regional Seminar – . Baltimore, MD. – June 2013. Division of Grants Compliance and Oversight. Office of Policy for Extramural Research Administration, OER. National Institutes of Health, DHHS . NIH Regional Seminar – . New Orleans. – . May. 2017. High Early Risk of SCA. Patients With Low EF Following PCI. NCDR CathPCI. ®. Registry. Mortality (STEMI vs NSTEMI). Case Presentation. Case Presentation. Hospital Course. Catheterization . Left Circumflex Artery . Program Goals. Epilepsy. Prevalence in the United States. Epilepsy. Burden. Epilepsy. Treatment. Major Depression is Associated With Uncontrolled Seizures. Adverse Events are Common in Epilepsy Patients. Changing Condition. Multiple Considerations To Balance. VALIANT. High Early Risk of SCA. Implications of . β. -Blocker Underuse . Prior To Device Implantation. DINAMIT Trial – 40-Day Wait. HAT - . Division of Grants Compliance and Oversight. Office of Policy for Extramural Research Administration, OER. National Institutes of Health, DHHS . NIH Regional Seminar – San Francisco, CA– October 2018. COORDINATED CARE IN CUSHING DISEASE Program Goals Cushing Disease: Importance of Diagnosis Patient Case Symptoms of Cushing Disease Physical Findings for Cushing Disease Diagnostic Tests Determining Cause of Cortisol Excess Program Goals. cHL. Overview. cHL. Poor Prognosis Risk Factors. Case Study 1. 45-Year-Old Man With Early-Stage cHL. Post-HDT/ASCT BV Maintenance. Phase 3 AETHERA Trial Design. Phase 3 AETHERA Trial. Efficacy Data. Med . sudent. name and institution. Attending radiologist (must be AMSER member) . and institution. Your institution logo here. Patient Presentation. Pertinent Labs. If any. What Imaging Should We Order?.